La Jolla Pharmaceutical Company (LJPC) analyst actions
Rating and price-target actions on LJPC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the LJPC overview →
No LJPC analyst action events in the measured window.
Nothing matched in the current window — the LJPC overview has every event we measure for this name.
Get an email when LJPC moves on news →Keep exploring
More LJPC: earnings → · SEC filings → · LJPC overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| OncoSec Medical Incorporated (ONCS) | 878 | -0.49% | 39% |
| Genocea Biosciences, Inc. (GNCA) | 873 | -0.47% | 40% |
| HTG Molecular Diagnostics, Inc. (HTGM) | 865 | -0.17% | 37% |
| Tivity Health, Inc. (TVTY) | 860 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.